#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14030	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2127	656.7	0	.	n	.	0	T755C	SNP	755	755	T	1026	1026	C	809	C,T	752,3	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14030	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2127	656.7	0	.	n	.	0	C1450T	SNP	1450	1450	C	1721	1721	T	759	T,C	681,1	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14030	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2127	656.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1455	1455	C	876	C,T	793,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	659	14030	16S	1529	1529	99.87	16S.l15.c4.ctg.1	2127	656.7	0	HET	.	.	.	A69G	.	69	69	A	340	340	A	785	A,G	593,119	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26232	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3565	733.7	0	.	n	.	0	G1337A	SNP	1337	1337	G	1713	1713	A	879	A,G	812,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26232	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3565	733.7	0	.	n	.	0	T1971C	SNP	1971	1971	T	2347	2347	C	798	C	709	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26232	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3565	733.7	1	SNP	n	A2045G	0	.	.	2045	2045	A	2421	2421	A	768	A	707	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26232	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3565	733.7	1	SNP	n	C2597T	0	.	.	2597	2597	C	2973	2973	C	841	C	773	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	26232	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3565	733.7	0	HET	.	.	.	C709T	.	709	709	C	1085	1085	C	845	C,T	443,321	.	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	27	1866	folP	852	852	100.0	folP.l15.c4.ctg.1	1481	125.0	1	SNP	p	R228S	0	.	.	682	684	CGC	978	980	CGC	215;216;215	C,A;G,A;C	196,1;199,1;197	folP.WHO_F_01537c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4630	gyrA	2751	2751	100.0	gyrA.l15.c17.ctg.1	3348	137.8	1	SNP	p	S91F	0	.	.	271	273	TCC	524	526	TCC	163;163;162	T;C;C	150;149;147	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4630	gyrA	2751	2751	100.0	gyrA.l15.c17.ctg.1	3348	137.8	1	SNP	p	D95N	0	.	.	283	285	GAC	536	538	GAC	167;167;168	G;A;C	146;146;148	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4630	gyrA	2751	2751	100.0	gyrA.l15.c17.ctg.1	3348	137.8	1	SNP	p	D95G	0	.	.	283	285	GAC	536	538	GAC	167;167;168	G;A;C	146;146;148	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1394	mtrR	633	633	99.21	mtrR.l15.c30.ctg.1	1280	108.6	0	.	p	.	0	A39T	NONSYN	115	117	GCC	452	454	ACC	178;179;178	ACC,ACCCC;C;C,A	165,1;157;154,1	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1394	mtrR	633	633	99.21	mtrR.l15.c30.ctg.1	1280	108.6	1	SNP	p	G45D	1	G45D	NONSYN	133	135	GGC	470	472	GAC	183;184;184	G;A;C	162;162;164	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	539	1394	mtrR	633	633	99.21	mtrR.l15.c30.ctg.1	1280	108.6	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	650	652	CAC	189;187;189	C;A,C;C	172;169,1;170	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	700	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	827	83.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4458	parC	2304	2304	99.78	parC.l15.c17.ctg.1	2921	152.0	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1543	1545	GCA	167;169;173	G;C;A	155;149;152	.	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4458	parC	2304	2304	99.78	parC.l15.c17.ctg.1	2921	152.0	1	SNP	p	D86N	0	.	.	256	258	GAC	496	498	GAC	192;191;191	G;A;C	175;170;176	parC.WHO_F_01444:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4458	parC	2304	2304	99.78	parC.l15.c17.ctg.1	2921	152.0	1	SNP	p	S87W	0	.	.	259	261	AGT	499	501	AGT	195;197;199	A;G;T	176;178;178	parC.WHO_F_01444:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4458	parC	2304	2304	99.78	parC.l15.c17.ctg.1	2921	152.0	1	SNP	p	S87R	0	.	.	259	261	AGT	499	501	AGT	195;197;199	A;G;T	176;178;178	parC.WHO_F_01444:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4458	parC	2304	2304	99.78	parC.l15.c17.ctg.1	2921	152.0	1	SNP	p	S87I	0	.	.	259	261	AGT	499	501	AGT	195;197;199	A;G;T	176;178;178	parC.WHO_F_01444:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_F_01444	parC.WHO_F_01444	1	1	539	4458	parC	2304	2304	99.78	parC.l15.c17.ctg.1	2921	152.0	1	SNP	p	S88P	0	.	.	262	264	TCC	502	504	TCC	201;207;208	T;C;C	180;185;188	parC.WHO_F_01444:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3988	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2528	156.7	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1476	1478	GGC	214;212;209	G;G;C	193;190;184	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.9.001	penA.9.001	1	1	27	3776	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2455	153.1	1	SNP	p	A311V	0	.	.	931	933	GCA	1345	1347	GCA	188;188;189	G;C,T;A	169;166,1;175	penA.9.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3776	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2455	153.1	1	SNP	p	I312M	0	.	.	934	936	ATC	1348	1350	ATC	191;190;192	A;T;C	177;175;174	penA.9.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3776	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2455	153.1	1	SNP	p	V316P	0	.	.	946	948	GTG	1360	1362	GTG	200;199;199	G;T;G	184;185;184	penA.9.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3776	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2455	153.1	1	SNP	p	V316T	0	.	.	946	948	GTG	1360	1362	GTG	200;199;199	G;T;G	184;185;184	penA.9.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3776	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2455	153.1	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1864	1866	ACC	224;225;226	A;C;C	191;197;198	penA.9.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3776	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2455	153.1	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1918	1920	GCG	188;188;189	G;C;G	164;152;160	penA.9.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3776	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2455	153.1	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1918	1920	GCG	188;188;189	G;C;G	164;152;160	penA.9.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3776	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2455	153.1	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2041	2043	GGC	181;180;182	G;G;C	160;159;160	penA.9.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3776	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2455	153.1	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2050	2052	GGC	181;179;181	G;G;C	155;156;158	penA.9.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.9.001	penA.9.001	1	1	27	3776	penA	1749	1749	100.0	penA.l15.c17.ctg.1	2455	153.1	1	SNP	p	L552S	0	.	.	1654	1656	CTG	2068	2070	CTG	159;159;162	C,CG;T;G	130,1;110;120	penA.9.001:1:1:L552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5490	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3031	180.5	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1608	1610	CCG	202;198;197	C;C;G,A	183;186;179,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1830	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1642	110.7	0	.	p	.	0	M83fs	FSHIFT	247	247	A	496	496	C	147	C,T	131,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2862	porB1b	1047	1047	98.47	porB1b.l15.c30.ctg.1	1467	193.9	0	.	p	.	0	T18M	NONSYN	52	54	ACG	331	333	ATG	252;249;249	A;T,C;G	231;224,1;227	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2862	porB1b	1047	1047	98.47	porB1b.l15.c30.ctg.1	1467	193.9	0	.	p	.	0	K143Q	NONSYN	427	429	AAA	706	708	CAA	238;235;239	C;A;A	219;217;220	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2862	porB1b	1047	1047	98.47	porB1b.l15.c30.ctg.1	1467	193.9	0	.	p	.	0	E212D	NONSYN	634	636	GAA	913	915	GAT	223;221;228	G;A;T	209;211;216	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2862	porB1b	1047	1047	98.47	porB1b.l15.c30.ctg.1	1467	193.9	0	.	p	.	0	H213D	NONSYN	637	639	CAT	916	918	GAT	227;226;223	G;A;T	215;214;213	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2862	porB1b	1047	1047	98.47	porB1b.l15.c30.ctg.1	1467	193.9	0	.	p	.	0	V215T	NONSYN	643	645	GTT	922	924	ACT	219;217;222	A;C;T	212;210;216	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2862	porB1b	1047	1047	98.47	porB1b.l15.c30.ctg.1	1467	193.9	0	.	p	.	0	I218T	NONSYN	652	654	ATC	931	933	ACC	232;231;234	A;C;C	219;221;224	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2862	porB1b	1047	1047	98.47	porB1b.l15.c30.ctg.1	1467	193.9	0	.	p	.	0	S220T	NONSYN	658	660	AGC	937	939	ACT	243;244;244	A;C;T,C	226;226;225,1	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2862	porB1b	1047	1047	98.47	porB1b.l15.c30.ctg.1	1467	193.9	0	.	p	.	0	R257M	NONSYN	769	771	AGG	1048	1050	ATG	259;260;261	A;T;G	233;234;236	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2862	porB1b	1047	1047	98.47	porB1b.l15.c30.ctg.1	1467	193.9	0	.	p	.	0	R258S	NONSYN	772	774	AGG	1051	1053	AGC	258;257;256	A;G;C	232;229;230	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2862	porB1b	1047	1047	98.47	porB1b.l15.c30.ctg.1	1467	193.9	0	.	p	.	0	A259G	NONSYN	775	777	GCT	1054	1056	GGT	253;252;249	G;G;T	226;226;223	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2862	porB1b	1047	1047	98.47	porB1b.l15.c30.ctg.1	1467	193.9	0	.	p	.	0	D297N	NONSYN	889	891	GAC	1168	1170	AAC	240;243;243	A;A;C	216;224;217	.	.
porB1b.WHO_P_02204c	porB1b.WHO_P_02204c	1	1	539	2862	porB1b	1047	1047	98.47	porB1b.l15.c30.ctg.1	1467	193.9	1	SNP	p	G120K	0	.	.	358	360	GGC	637	639	GGC	233;239;243	G,A,T;G,A;C,G	205,1,1;213,1;219,1	porB1b.WHO_P_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	11798	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4840	243.0	1	SNP	p	H553N	0	.	.	1657	1659	CAT	1966	1968	CAT	260;258;259	C;A;T	240;241;242	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_F_02142c	rpsJ.WHO_F_02142c	1	1	27	1288	rpsJ	312	312	100.0	rpsJ.l6.c30.ctg.1	951	134.2	1	SNP	p	V57M	0	.	.	169	171	GTG	485	487	GTG	270;271;269	G,A;T,C;G	248,1;246,1;244	rpsJ.WHO_F_02142c:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
